Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Keratosis, Actinic × green tea extract polyphenone E × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Keratosis, Actinic 1 High-grade Anal Intraepithelial Neoplasia 1

Interventions

3-ingenyl angelate 11 Photochemotherapy 6 Imiquimod 6 Fluorouracil 5 Aminolevulinic Acid 5 methyl 5-aminolevulinate 4 Gels 4 Diclofenac 4 Cryotherapy 3 tirbanibulin 2 Therapeutics 2 BF-200 ALA 2 green tea extract polyphenone E 1 cetyl alcohol, propylene glycol, sodium lauryl sulfate non-lipid cleansing lotion 1 Solutions 1 Ointments 1 LEO 43204 1 Drugs, Generic 1 Deoxyribonuclease (Pyrimidine Dimer) 1 Cryosurgery 1 Cosmetics 1 5-fluorouracil, salicylic acid drug combination 1 1-phenyl-3,3-dimethyltriazene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07137819 2025-08-22

EXACT-1

Aresus Pharma GmbH

Phase 3 Recruiting

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡